Venkatesh Ariyamuthu is a Nephrology physician affiliated with University of Arizona. OpenAlex indexes 44 publications with 396 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
3838 N Campbell Ave
Tucson, AZ 857191454
Telephone
520-626-5576Provider last certified this registry record 6 Mar 2026.
Industry payments
5 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20252 payments
- Merck Sharp & Dohme LLCProgram year20255 payments
- Takeda Pharmaceuticals U.S.A., Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Metabolism & gastrointestinal
30.7%Corticosteroid7.8%Prednisone100%Part D≥26 patientsSGLT2 inhibitor6.3%Jardiance77%Farxiga23%Part D<11 patients+ 4 more classes in this area
Cardiovascular
29.9%Beta blocker9.8%Carvedilol84%Metoprolol Tartrate17%Part D<11 patientsStatin7.3%Rosuvastatin Calcium52%Atorvastatin Calcium48%Part D<11 patients+ 3 more classes in this area
Anti-infectives
22.3%Azole Antifungal12%Fluconazole87%Posaconazole13%Part D<11 patientsCytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor3.8%Valganciclovir Hcl100%Part D≥21 patients+ 3 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Unintended consequences of the Kidney Safety Net policy: A call for refined eligibility criteria
American Journal of Transplantation
2026 - Integrating EFNEP Into Hemodialysis and Kidney Transplant Care Plans to Improve Food Skills, Diet Quality, and Clinical Indicators: Study Protocol
Current Developments in Nutrition
2026 - How do we increase deceased donor kidney utilization and reduce discard?
Current Opinion in Organ Transplantation
2025 - Predicting Simultaneous Heart Kidney Allocation and Posttransplant Adverse Kidney Outcomes
Kidney International Reports
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Joseph Alpert, MD
University of Arizona
Karl Kern, MD
University of Arizona
Peter Reaven, MD
University of Arizona
Alison Stopeck, MD
University of Arizona
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”